期刊論文1. | Gardner, Peter J.(2004)。Our Intellectual Property World: Charting a Course from Ancient Native Cultures to the Threshold of the Future on a Roiled Sea of Macroeconomics, Morality and Ethics。Idea,44,105+237。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
2. | Debra L.、Greenfield J. D.(2003)。Greenberg v. Miami Children’s Hospital: Unjust Enrichment and the Patenting of Human Genetic Material。Ann.health L.,15,213+274。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
3. | Morin, Eileen(1997)。Of Mice and Men: The Ethics of Patenting Animals。Health Law Journal,5。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
4. | Ragavan, Srividhya(2001)。Protection of Traditional Knowledge。MINN. INTELL. PROP. REV.,2(1),27-32。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
5. | Helfer, Laurence R.(2003)。Human Rights and Intellectual Property: Conflict or Coexistence?。Minnesota Journal of Law, Science & Technology,5,47。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
6. | Brownsword, Roger(2005)。Stem Cells and Cloning: Where the Regulatory Consenus Falls。New Eng.L.Rev.,39,535。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
7. | Gargano, Brain(2005)。The Quagmire of DNA Patents: Are DNA Sequences More Than Chemical Compositions of Matter。Syracuse Sci.&Tech L.Rep,3。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
8. | Stankovic, Bratislav(2005)。Patenting the Minotaur。Rich.J.L.&Tech,12,5。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
9. | Kevles, Daniel J.、Berkowitz, Ari(2001)。The Gene Patenting Controversy : A Convergence of Law、Economics Interests and Ethics。Brooklyn L.Rev,67,233。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
10. | Vaver, David(2004)。Canada’s Intellectual Property Framework : A Comparative Overview。I.P.J.,17,125。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
11. | Nico, Diannel(2005)。On The Legality of Gene Patents。Melbourne U.L.R,29,809。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
12. | Gitter, Donna M.(2001)。Led Astray by Moral Compass : Incorporating Morality into European Union Biotechnology Patent Law。Berkeley J.Int’l L.,19,1。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
13. | Duane Nash, M.D(2002)。Rocommended Response for Human Cloning Patent Applications。Idea,142,279。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
14. | Vogelsang-Wenke, Heike(2004)。Patenting of Stem Cells and Processes Involving Stem Cells According to the Rules of the European Patent Convention。Biotechlr,23,155。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
15. | Paradis, Jordan(2004)。Eueopean Opposition to Control Over Predictive Cancer Testing and the Inherent Implications for U.S.Patent Law and Public Policy : A Case Study of the Myriad Genetics’BRCA Patent Controversy。Food Drag L.J.,59,133。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
16. | Restaino, Lesli G.、Halpem, Steven E.、Tang, Eric L.(2003)。Patenting DNA-Related Inventions in the Europe Union,United States and Japan: A Trilateral Approach or A Study in Contrast。UCLA J.L.&Tech,2。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
17. | Bagley, Margo A.(2003)。Patent first, ask questions later: morality and biotechnology in patent law。William and Mary Law Review,45(2),469-547。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
18. | Chavez, Mark(2003)。Gene Patenting : Do the Ends Justify the Means。Comp. L. Rev_&Tech.J.,7,225。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
19. | Kamber, Matthias(2003)。Coming Out of the Maze : Canada Grants the Harvard Mouse Patent。Geo.Wash.Int’l.Rev,35,761。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
20. | Kim, Mikyung(2005)。An Overview of the Regulation and Patentability of Human Cloning and Embryonic Stem Cell Research in the United States and Anti-Cloning Legislation in South Koera。Santa Clara Computer&High Tech.LJ,21,645。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
21. | Momeault, Monique(2005)。Stem Cell Research and Human Cloning: Where Do We Draw the Line ?。New Eng.L.Rev.,39,523。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
22. | de Carvalho, Nuno Pires(2004)。The Problem of Gene Patents。Wash.U.GIobal StudL.Rev,3,701。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
23. | Yu, Peter K.(2006)。The First Ten Years of the TRIPs Agreement : TRIPs and Its Discontents。Marq.InteIl.PropL.Rev,10,369。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
24. | Brownsword, Roger(2004)。Regulating Human Genetics: New Dilemmas for A New Millennium。Med.L.Rev.,12,14。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
25. | Crespi, R.Stephen(2003)。Patenting and Ethics--A Dubious Connection。J.Pat.& Trademark Off.Soc’y,85,31。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
26. | Schmieder, Sandra(2004)。Scope of Biotechnology Inventions in the United and in Europe。Santa Clara Computers&High TechJ,21,163。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
27. | Philips, Valerie J.(2005)。Half-Human Creatures,Plants&Indigenous Peoples : Musings on Ramifications of Western Notions of Intellectual Property and the Newman-Rifkin Attempt to Patent a Theoretical Half-Human Creature。Santa Clara Computer and High Tech,21,83+383。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
28. | Harty, William W.(1998)。Morality : The Starting Place for the Debate Over Human Cloning。Regent U.L.Rev,11,353。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
29. | Cripps, Yvonne(2004)。The Art Science of Genetic Modification : Re-Engineering Patent Law and Constitutional Orthodoxies。IndJ.Global Legal Stud,11,1。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
30. | 余信達(20041000)。從人性尊嚴與倫理道德之定位探索基因相關技術之可專利性。月旦法學,113,175-195。 延伸查詢![new window](/gs32/images/newin.png) |
31. | 王服清(20051200)。「歐盟生物科技專利指令」之淺析。財產法暨經濟法,4,71-122。 延伸查詢![new window](/gs32/images/newin.png) |
32. | 李惠宗(20011200)。禁譜辦公室戀曲--「基本權第三人效力」或「基本權衝突」。月旦法學,79,8-9。 延伸查詢![new window](/gs32/images/newin.png) |
33. | 孫玉苓、林志生、周佑吉(20030800)。我國專利法下人類胚幹細胞相關發明可專利性之研究。科技法律透析,15(8),31-45。 延伸查詢![new window](/gs32/images/newin.png) |
34. | 陳英鈐(20060400)。人類胚胎幹細胞專利與胚胎保護--一部98/44/EC指令各自表述。科技法學評論,3(1),75-132。 延伸查詢![new window](/gs32/images/newin.png) |
35. | 陳文吟(20030700)。專利制度就基因工程發展的因應之道。應用倫理研究通訊,27,25-29。 延伸查詢![new window](/gs32/images/newin.png) |
36. | 陳英鈐(2001)。人類胚胎幹細胞議題。政大法學評論,67,34。 延伸查詢![new window](/gs32/images/newin.png) |
37. | 陳春生(1999)。基因工程應用之憲法問題。憲政時代,25(2),39-48。 延伸查詢![new window](/gs32/images/newin.png) |
38. | 張文貞、牛惠之(20030700)。淺談人類基因專利:科技發展、倫理與法律的三角習題。應用倫理研究通訊,27,42-47。 延伸查詢![new window](/gs32/images/newin.png) |
39. | 魏衍亮、葉東蕾(20030800)。從公序良俗原則看中國大陸的制度變遷。東吳法律學報,15(1),285-344。 延伸查詢![new window](/gs32/images/newin.png) |
40. | Morrow, A. David、Ingram, Colin B.(2005)。Of Transgenic Mice and Roundup Ready Canola : The Decisions of Supeeme Court of Canada in Harvard College v. Canada Monsanto v. Schmeiser。U.B.C.L.Rev.,38,189。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
41. | Brashear, Andeea D.(2001)。Envolving Biotechnology Patent Laws in the United States and Europe: Are They Inhibiting Disease Research。Ind.Int' l&Comp.L.Rev.,12,183。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
42. | Oddi, A. Samuel(2006)。Regeneration in American Patent Law: Statutory Subject Matter。Idea,46,491。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
43. | Pitcher, Amanda S.(2003)。Symposium: ’’At the Crossroads~ Public/Private Priorities Concerning Access to Genetic Information”: Comment to First Impression,Genes are Patentable: Should There be Limitations。J. Health Care L. & Pol’y,6,284。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
44. | Meyers, Abbey S.(1996)。Genetics and the Law: The Ethical, Legal, and Social Implications of Genetic Technology and Biomedical Ethics: "Intellectual Property at the Public-Private Divide: "A Response。U Chi L Sch Roundtable,3,581。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
45. | Kamage, Andrea、Heider, Julie(2005)。The Blurry Biotech Line。IP Law & Business,2005(6),46。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
46. | Enerson, Benjamin D.(2004)。Protecting Society from Patently Offensive Inventions: The Risk of Reviving the Moral Utility Doctrine。Comell L.Rev.,89,685。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
47. | Sommer, Andrew R.(2005)。Trouble on the Commons: A Lockean Justification for Patent Law Harmonization。J.Pat. & Trademark Off. Soc' y,87,141。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
48. | Smith, Andrew R.(2003)。Monster at the Patent Office: The Inconsistent Conclusions of Moral Utility and the Controversy of Human Cloning。Depaul L.Rev.,53,159。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
49. | Macintosh, Constance(2005)。Indigenous Self-Determination and Research on Human Genetic Material。Health L.J.,13,213。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
50. | Ho, Cynthia M.(2000)。Patent Law and Policy Symposium: Re-Engineering Patent Law: The Challenge of New Techologies: PartIII: International and Comparative Law Issues: Splicing Morality and Patent Law: Issues? Arising from Mixing Mice and Men。Wash. U. J. L. & POl' y,2,247。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
51. | Ho, Cynthia M.(2002)。Biotechnology Symposium: Who Deserves the Patent Pot of Gold ?: An Inquiry into the Proper Inventorship of Patent-Based Discoveries。Hous. J. Health L. & Pol’y,2002,107。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
52. | Smith, Cynthia(2005)。A Practical Guide to Chinese Patent Law。Seton Hall Legis. J.,29,643。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
53. | Vidergar, Cyril R.(2002)。Biomedical Patening: Permitted, But Permissible ?。Santa Clara Computer & High Tech L.J.,19,253。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
54. | Bennett, D. Scott(2006)。Chimera and the Continuum of Humanity: Erasing the Line of Constitutional Personhood。Emory L.J.,55,347。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
55. | Thomas, David、Richards, Georgina A.(2004)。The Importance of the Morality Exception Under the European Patent Convention: The Oncomouse Case Continues。E.I.P.R.,26(3),97-104。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
56. | Vaver, David(2002)。Need Intellectual Property be Everywhere ? Against Ubiquity and Uniformity。Dalhouse L.J.,25,1。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
57. | McCall, Diana D.(2003)。Stating the Obvious: Patents and Biological Material。U.III.J. L.Tech. & Pol’y,2003,239。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
58. | Gitter, Donna M.(2001)。International Conflicts Over Patenting Human DNA Sequences in the United States and the European Union – An Argument for Compulsory Licensing and A Fair-Use Exemption。N.Y.U.L.Rev.,76,1623。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
59. | Toumi, Emma(2004)。EC: Patents-Biotech Patents-Questions of Morality。E.LRR,26(2),N15-16。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
60. | Gold, E. Richard(2000)。Biomedical Patents and Ethics 'A Canadian Solution。McGill L.J.,45,413。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
61. | Pellegrino, E. D.(2002)。Balancing Science、Ethics and Politics: Stem Cell Research、A Paradigm Case。J.Contemp.Health L.&Pol’y,18,591。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
62. | Greely, Henry T.(2006)。Neuroethics and ELSI: Similarities and Differences。Min.J L.Sci &Tech.,7,599。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
63. | Bender, Erin Kathleen(2003)。North and South : The WTO、TRIPS and The Source of Biopiracy。Tulsa J.Comp. & Int'l.,11,281。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
64. | Wei Sze Shun, George(2003)。Mus Musculus and Homo Sapiens–Metaphyics and the Canadian Supreme Court。Sing.J. Legal Stud.,2003,38。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
65. | Washko, Frank M.(2006)。Current Development 2005-2006: Should Ethics Play a Special Rple in Patent Law?。Geo.J.Legal Ethics,19,1027。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
66. | Mgbeoji, Ikechi(2004)。The “Terminator"Patent and Discontents :Rethinking the Normative Deficit in Utility Test of Modern Patent Law。St Thomas L.Rev.,17,95。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
67. | Koopman, Jerzy(2002)。The Patentibility of Transgenic Animals in United States of American and the European Union: A Proposal for Harmonization。Fordham Intell. Prop. Media & Ent.L.J.,13,103。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
68. | Jones, Jackie(2004)。" Common Constitutional Traditions” : Can Meaning Human Dignity under German Law Guide the European Court of Justice。P. L., SPR,2004,167-187。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
69. | Williams, J. Jason(2005)。rotecting the Frontiers of Biotechnology Beyond the Genome: The Limits of Patent Law in the Face of the Proteomics Revolution。Vand. L. Rev.,58,955。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
70. | Chen, Jim。There’s No Such Thing as Biopiravy......and It's a Good Thing。McGeorge L.Rev.,37,1。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
71. | Spindler, Karen A.(2001)。Current Patent Protection Grantedfor Genetically Modified Organisms under the European Patent Convention and the Scandal of EP 0695351。Santa Clara Computer & High Tech L.J3,18,95。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
72. | Jordan K.Paradise(2005)。Recent Developments - Lessons from the European Union: The Need for a Post-Grant Mechanism for Third-Party Challenge to U.S Patents。Minn.J.L.Sci.&Tech.,1,315。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
73. | Kevin J.Nowak(2005)。Staying Within the Negotiated Framework: Abiding by the Non-Discrimination Clause in TRIPS Article。Mich.J.Int’l,27,899。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
74. | Cirlin, Lauren(2003)。Human or Animal: A Resolution to the Biotechnological Blurring of the Lines。Sw.U.Rev.,32,501。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
75. | Nathan A.Adams, IV(2004)。Creating Clones、Kids & Chimera: Liberal Democratic Compromise at the Crossroads。Issues L. & Med.,20,3。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
76. | Malinowski, Michael J.、Rao, Radhika(2004)。Legal History and Legal Theory: Legal Limitations on Genetic Research and the Commercialization of its Results。Am. J.Comp L.,54,45。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
77. | Campbell, Randy L.(2003)。Global Patent Law Harmonization: Benefits and Implemenation。Ind.Int’l &Comp.L.Rev.,13,605。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
78. | Brownsword, Roger(2003)。Ahrens Torts Seminar Genomic Torts: An Interest in Human Dignity as the Basis for Genomic Torts。Washburn L.J.,42,413。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
79. | Eisenberg, Rebecca S.(1996)。Genetics and the Law - The Ethical、Legal、and Social Implications of Genetic Technology and Biomedical Ethics : Intellectual Property at the Public-Private Divide : The Case of Large-Scale cDNA Sequencing。U Chi L Sch Roundtable,3,557。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
80. | Guerra, Richard(2003)。Therapeutic Cloning as Proper Subject Matter for Patent Eligibilty。Idea,41,695。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
81. | Epstein, Richard A.(1996)。Genetics and the Law: The Ethical、Legal、and Social Implications of Genetic Technology and Biomedical Ethics: Property Rights in cDNA Sequences: A New Resident for the Public Domain。U Chi L Sch Roundtable,3,575。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
82. | Coughlin, Sean M.(2006)。The Newman Application and the Uspto ,sUnnecessary Response: Patentability of Humans and Human Embryos。Chi. Kent J. Mell. Prop.,5,90。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
83. | Muscati, Sina(2005)。Terminator Techology - Protection or a Threat to the Patent System。IDEA,45,477。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
84. | Wei, Tanya(2003)。Patenting Genomic Techology-2001 Utility Examination Guidelines: An Incomplete Remrdy in Need of Prompt Reform。Santa Clara L.Rev.,44,307。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
85. | Oriola, Taiwo A.(2002)。Ethical and Legal Issues in Singapore Biomedical Research。Pacific Rim Law and Policy Journal,11(3),498-529。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
86. | Spranger, Tade Matthias(2002)。Europe’s Biotech Patent Landscape: Conditions and Recent Developments。Minn.Intell.Prop.Rev.,3,235。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
87. | Lim, Wendy(2003)。Towards Developing a Natural Law Jurisprudence in he U.S. Patent System。Santa Clara Computers & High Tech.L.J.,19,559。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
88. | Kongolo, Tshimanga(2002)。Morocco’s Patent System and its International Connection。IDEA,42,181。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
89. | Vinciguerra, Vincenzo(2006)。A Brief Essay on Importance of Time in International Conventions of Intellectual Property Rights。Akron L.Rev.,39,635。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
90. | Chang, Wesley(2004)。Note - ArrestedDevelopment - Patent Laws,Embryonic Stem Cell Research,and the Organ Black Market。Sw.J.L&Trade Am.,10,407。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
91. | 許育典(20030500)。學術自由在宗教大學的實踐--天主教大學憲章案的合憲性探討。國立臺灣大學法學論叢,32(3),65-115。 延伸查詢![new window](/gs32/images/newin.png) |
92. | 許耀華(20051000)。由愛丁堡一案探討歐洲專利局對人類胚胎幹細胞可專利性之立場。政大智慧財産評論,3(2),43-49。 延伸查詢![new window](/gs32/images/newin.png) |
93. | 馮達發(20021200)。關於生物相關發明專利審査基準之淺論。萬國法律,126,57-62。 延伸查詢![new window](/gs32/images/newin.png) |
94. | Lori, B.、Andrews, J. D.、Jordan Paradise, J. D.(2005)。Gene Patents: The Need for Bioethics Scrutiny and Legal Change。Yale J.Health Pol’y L.& Ethics,5,403。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
95. | Nenow, Lydia(2001)。To Patent or Not to Patent: The European Union's New Biotech Directive。Houston Journal of International Law,23,569。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
96. | Nwabuezie, Remigius N.(2005)。What Can Genomics and Health Biotechnology Do for Developing Countries?。AlbL.J.Sci&Tech.,15,369。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
97. | Ghosh, Shubha(2004)。Patents and the Regulatory State : Rethinking the Patent Bargain Metaphor after Eldred。Berkeley TechJ,19,1315+1367。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
98. | 許育典(20051200)。多元文化國下色情管制的憲法正當性--以中央大學性/別研究室動物戀網頁案為例。東吳法律學報,17(2),1-92。 延伸查詢![new window](/gs32/images/newin.png) |
99. | Cann, Jr. Wesley A.(2004)。On the Relationship Between Intellectual Property Rights and the Need of Less-Developed Countries for Access to Pharmaceuticals: Creating Legal Duty to Supply under a Theopy of Progressive Global Constitutionalism。U.PaJ.Infl Econ.L.,25(3),755-944。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
100. | 李惠宗(20051100)。死後取精 基本權與人性尊嚴的衝突?。月旦法學教室,37,6-7。 延伸查詢![new window](/gs32/images/newin.png) |
101. | 劉憶成(20050600)。專利審查應否援用公序良俗作為審定之標準--從人類胚胎幹細胞之可專利性談起。銘傳大學法學論叢,4,197-244。 延伸查詢![new window](/gs32/images/newin.png) |
102. | 謝銘洋、宋皇志(20041000)。基因轉殖植物的智慧財產權保護。清華科技法律與政策論叢,1(1),165-190。 延伸查詢![new window](/gs32/images/newin.png) |
103. | 牛惠之(20050100)。「科技法律」議題之研究。月旦法學,116,191-207。 延伸查詢![new window](/gs32/images/newin.png) |
104. | Jackson, Christopher(2004)。Learning from the Mistakes of the Past: Disclosure of Financial Conflicts of Interest and Genetic Research。Richmond Journal of Law & Technology,11,4。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
105. | Bagley, Margo A.(2005)。Stem cells, cloning and patents: what's morality got to do with it?。New England Law Review,39(3),501-509。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
106. | 李震山(20030200)。行政權得依法介入私權爭執之法理基礎。臺灣本土法學雜誌,43,123-127。 延伸查詢![new window](/gs32/images/newin.png) |
107. | Chambers, Jasemine(2002)。Patent Eligibility of Biotechnological Inventions in the United States, Europe, and Japan: How much patent policy is public policy?。The George Washington International Law Review,34(1),226。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
108. | 謝銘洋(20030100)。從歐洲觀點探討幹細胞相關發明之可專利性。生物科技與法律研究通訊,17/18,118-123。 延伸查詢![new window](/gs32/images/newin.png) |
109. | 周志宏、陳春生、陳慈陽(19991000)。「生物科技與憲法」學術研討會。憲政時代,25(2),3-60。 延伸查詢![new window](/gs32/images/newin.png) |
110. | 何建志(20030700)。基因專利違反道德?。應用倫理研究通訊,27,55-63。 延伸查詢![new window](/gs32/images/newin.png) |
111. | 范建得、胡均立、邱永和(20021200)。自經濟分析之觀點論我國生物科技應有之財產法制。全國律師,6(12),9-28。 延伸查詢![new window](/gs32/images/newin.png) |
112. | 陳志忠(20030700)。專利法上公序良俗條款初探:以基因生物體為例。應用倫理研究通訊,27,64-70。 延伸查詢![new window](/gs32/images/newin.png) |
113. | 陳俊寰(20030500)。生物科技專利申請之可實施性要件。智慧財產權,53,18-33。 延伸查詢![new window](/gs32/images/newin.png) |
114. | 李震山(20030500)。基本權各論基礎講座(1)--人性尊嚴。法學講座,17,1-17。 延伸查詢![new window](/gs32/images/newin.png) |
115. | 李震山(20011200)。「複製人」科技發展對既有法律思維與制度之衝擊--以基本權利保障為例。月旦法學,79,158-171。 延伸查詢![new window](/gs32/images/newin.png) |
116. | 陳文吟(19970700)。從美國核准動物專利之影響評估動物專利之利與弊。國立臺灣大學法學論叢,26(4),173-231。 延伸查詢![new window](/gs32/images/newin.png) |
117. | Whelan, Marina L.(2006)。What、if Any, are the Ethical Obligations of the U.S.Patent Office ? A Closer Look at the Biological Sampling of Indigenous Gropes。Duke L.&Tech.Rev.,2006,14。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
118. | 程明修(20041000)。契約自由與國家之保護義務。憲政時代,30(2),195-227。 延伸查詢![new window](/gs32/images/newin.png) |
119. | 蔡維音(19920700)。德國基本法第一條「人性尊嚴」規定之探討。憲政時代,18(1),36-48。 延伸查詢![new window](/gs32/images/newin.png) |
120. | 陳文吟(20011200)。由胚胎幹細胞研究探討美國專利法上「道德」實用性因應生物科技的必要性。臺北大學法學論叢,49,179-223。 延伸查詢![new window](/gs32/images/newin.png) |
121. | 李震山(20030800)。憲法中基本權利保障規範間之關係。臺灣本土法學雜誌,49,127-133。 延伸查詢![new window](/gs32/images/newin.png) |
122. | Nard, Craig Allen(2003)。In Defense of Geographic Disparity。MINNESOTA LAW REVIEW,88,222。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |
123. | Ewelukwa, Uché(2005)。Patent Wars in the Valley of the Shadow of Death: The Pharmaceutical Industry, Ethics, and Global Trade。UNIVERSITY MIAMI LAW REVIEW,59,203。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) |